These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82. Distinct mechanisms survey the structural integrity of HLA-B*27:05 intracellularly and at the surface. Hein Z; Borchert B; Abualrous ET; Springer S PLoS One; 2018; 13(8):e0200811. PubMed ID: 30071035 [TBL] [Abstract][Full Text] [Related]
83. The Role of Molecular Flexibility in Antigen Presentation and T Cell Receptor-Mediated Signaling. Natarajan K; Jiang J; May NA; Mage MG; Boyd LF; McShan AC; Sgourakis NG; Bax A; Margulies DH Front Immunol; 2018; 9():1657. PubMed ID: 30065727 [TBL] [Abstract][Full Text] [Related]
84. Selected HLA-B allotypes are resistant to inhibition or deficiency of the transporter associated with antigen processing (TAP). Geng J; Zaitouna AJ; Raghavan M PLoS Pathog; 2018 Jul; 14(7):e1007171. PubMed ID: 29995954 [TBL] [Abstract][Full Text] [Related]
85. Peptide exchange on MHC-I by TAPBPR is driven by a negative allostery release cycle. McShan AC; Natarajan K; Kumirov VK; Flores-Solis D; Jiang J; Badstübner M; Toor JS; Bagshaw CR; Kovrigin EL; Margulies DH; Sgourakis NG Nat Chem Biol; 2018 Aug; 14(8):811-820. PubMed ID: 29988068 [TBL] [Abstract][Full Text] [Related]
86. Crystal structure of a TAPBPR-MHC I complex reveals the mechanism of peptide editing in antigen presentation. Jiang J; Natarajan K; Boyd LF; Morozov GI; Mage MG; Margulies DH Science; 2017 Nov; 358(6366):1064-1068. PubMed ID: 29025991 [TBL] [Abstract][Full Text] [Related]
87. Direct evidence for conformational dynamics in major histocompatibility complex class I molecules. van Hateren A; Anderson M; Bailey A; Werner JM; Skipp P; Elliott T J Biol Chem; 2017 Dec; 292(49):20255-20269. PubMed ID: 29021251 [TBL] [Abstract][Full Text] [Related]
88. Partial Dissociation of Truncated Peptides Influences the Structural Dynamics of the MHCI Binding Groove. Fisette O; Wingbermühle S; Schäfer LV Front Immunol; 2017; 8():408. PubMed ID: 28458665 [TBL] [Abstract][Full Text] [Related]
89. Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation. Wieczorek M; Abualrous ET; Sticht J; Álvaro-Benito M; Stolzenberg S; Noé F; Freund C Front Immunol; 2017; 8():292. PubMed ID: 28367149 [TBL] [Abstract][Full Text] [Related]
90. Recent advances in Major Histocompatibility Complex (MHC) class I antigen presentation: Plastic MHC molecules and TAPBPR-mediated quality control. van Hateren A; Bailey A; Elliott T F1000Res; 2017; 6():158. PubMed ID: 28299193 [TBL] [Abstract][Full Text] [Related]
91. ERAP1-ERAP2 dimers trim MHC I-bound precursor peptides; implications for understanding peptide editing. Chen H; Li L; Weimershaus M; Evnouchidou I; van Endert P; Bouvier M Sci Rep; 2016 Aug; 6():28902. PubMed ID: 27514473 [TBL] [Abstract][Full Text] [Related]
92. Molecular mechanism of peptide editing in the tapasin-MHC I complex. Fisette O; Wingbermühle S; Tampé R; Schäfer LV Sci Rep; 2016 Jan; 6():19085. PubMed ID: 26754481 [TBL] [Abstract][Full Text] [Related]
93. HLA class I is most tightly linked to levels of tapasin compared with other antigen-processing proteins in glioblastoma. Thuring C; Follin E; Geironson L; Freyhult E; Junghans V; Harndahl M; Buus S; Paulsson KM Br J Cancer; 2015 Sep; 113(6):952-62. PubMed ID: 26313662 [TBL] [Abstract][Full Text] [Related]
94. The Carboxy Terminus of the Ligand Peptide Determines the Stability of the MHC Class I Molecule H-2Kb: A Combined Molecular Dynamics and Experimental Study. Abualrous ET; Saini SK; Ramnarayan VR; Ilca FT; Zacharias M; Springer S PLoS One; 2015; 10(8):e0135421. PubMed ID: 26270965 [TBL] [Abstract][Full Text] [Related]
95. Zooming into the binding groove of HLA molecules: which positions and which substitutions change peptide binding most? van Deutekom HW; Keşmir C Immunogenetics; 2015 Aug; 67(8):425-36. PubMed ID: 26040913 [TBL] [Abstract][Full Text] [Related]
96. Plasticity of empty major histocompatibility complex class I molecules determines peptide-selector function. van Hateren A; Bailey A; Werner JM; Elliott T Mol Immunol; 2015 Dec; 68(2 Pt A):98-101. PubMed ID: 25818313 [TBL] [Abstract][Full Text] [Related]
97. The first step of peptide selection in antigen presentation by MHC class I molecules. Garstka MA; Fish A; Celie PH; Joosten RP; Janssen GM; Berlin I; Hoppes R; Stadnik M; Janssen L; Ovaa H; van Veelen PA; Perrakis A; Neefjes J Proc Natl Acad Sci U S A; 2015 Feb; 112(5):1505-10. PubMed ID: 25605945 [TBL] [Abstract][Full Text] [Related]